04:21 PM EDT, 10/02/2024 (MT Newswires) -- Biohaven ( BHVN ) said Wednesday it has closed an underwritten public offering of about 6.1 million shares, including the full exercise of an over-allotment option, at $47.50 per share, raising about $287.5 million.

Net proceeds will be used for general corporate purposes, the clinical-stage biopharmaceutical company said.

Price: 50.15, Change: -0.85, Percent Change: -1.67